Morgan Stanley 13D and 13G filings for NeuroPace, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-04 12:50 pm Purchase |
2024-12-31 | 13G | NeuroPace, Inc. NPCE |
MORGAN STANLEY MS |
2,489,391 8.300% |
28,675 (+1.17%) |
Filing |
| 2024-02-09 1:25 pm Purchase |
2023-12-31 | 13G | NeuroPace, Inc. NPCE |
MORGAN STANLEY MS |
2,460,716 9.400% |
272,123 (+12.43%) |
Filing |
| 2023-02-10 1:12 pm Purchase |
2022-12-30 | 13G | NeuroPace, Inc. NPCE |
MORGAN STANLEY MS |
2,188,593 8.800% |
2,188,593 (New Position) |
Filing |